KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Non-Current Deffered Revenue: 2010

Historic Non-Current Deffered Revenue for Charles River Laboratories International (CRL) over the last 1 years, with Dec 2010 value amounting to $24.7 million.

  • Charles River Laboratories International's Non-Current Deffered Revenue was N/A to $25.4 million in Q3 2011 from the same period last year, while for Sep 2011 it was $25.4 million, marking a year-over-year change of. This contributed to the annual value of $24.7 million for FY2010, which is N/A change from last year.
  • Charles River Laboratories International's Non-Current Deffered Revenue amounted to $24.7 million in FY2010.
  • Over the past 5 years, Charles River Laboratories International's Non-Current Deffered Revenue peaked at $24.7 million during FY2010, and registered a low of $24.7 million during FY2010.
  • Over the past 1 years, Charles River Laboratories International's median Non-Current Deffered Revenue value was $24.7 million (recorded in 2010), while the average stood at $24.7 million.